The pathologic relevance of metabolic criteria in patients with biopsy-proven nonalcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease: A multicenter cross-sectional study in China
Authors:
- 1 October 2021
- journal article
- research article
- Published by Elsevier in Hepatobiliary & Pancreatic Diseases International
- Vol. 20 (5) , 426-432
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studiesInternational Journal of Surgery, 2014
- Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndromeThe Lancet Diabetes & Endocrinology, 2014
- Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver diseaseHepatology, 2014
- Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosisNature Reviews Gastroenterology & Hepatology, 2013
- Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastographyGut, 2011
- Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis CJournal of Hepatology, 2011
- Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis BGut, 2008
- Liver Fat in the Metabolic SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2007
- Use and Abuse of HOMA ModelingDiabetes Care, 2004
- Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆Gastroenterology, 1999